So far, tissue-specific alternative splicing regulation has been understood from the viewpoint of the balance between enhancement and silencing of the alternative exons mediated by trans-factors through specific cis-elements [3].
Attempts to construct an entire larynx have involved several approaches, and so far, tissue engineering has only been used for partial laryngeal reconstruction.
The presence of NRP1 may compensate for the inability of longer isoforms to diffuse far in tissues.
Amplification was carefully assessed by fluorescence in situ hybridization on tissue microarrays containing triplicate 2 mm cores/sample, which is far more tissue than used in most tissue microarray studies.
Here Pomahac would have to remove far more tissue in a fraction of the time.
Thus far bone tissue engineering has not lead to an implant which could be used as alternative in bone replacement surgery.
So far, nine tissue-specific cytoplasmic FABPs with molecular mass 14 15 kea have been identified, including cytosolic epidermal FABP (FABP5, also termed E-FABP or PA-FABP).
Several human microRNAs identified so far show tissue or development stage-specific expression profiles, suggesting that they are integrated in the regulatory networks defining the cellular characteristics of the immune system.
So far, three tissue miRNAs (miR-21-5p, miR-29-3p, miR-148-3p) have been examined in multiple studies, of which miR-21-5p is the most promising prognostic marker, yet further prospective validation studies are required before it can go into clinical use.
The TM phantom was designed to improve a widely used standard bovine serum albumin (BSA) polyacrylamide hydrogel (PAG), which attenuated ultrasound far less than tissue and, unlike tissue, did not scatter ultrasound.
